The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Methyl-N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)benzamide ID: ALA472921
PubChem CID: 24971207
Max Phase: Preclinical
Molecular Formula: C22H19N5O
Molecular Weight: 369.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(C(=O)Nc2cccc(Nc3nc(-c4cccnc4)c[nH]3)c2)c1
Standard InChI: InChI=1S/C22H19N5O/c1-15-5-2-6-16(11-15)21(28)25-18-8-3-9-19(12-18)26-22-24-14-20(27-22)17-7-4-10-23-13-17/h2-14H,1H3,(H,25,28)(H2,24,26,27)
Standard InChI Key: RXNJNCJKYXUTGK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
4.3569 3.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3557 2.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0706 2.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7870 2.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7841 3.2662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0688 3.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5021 2.0243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2159 2.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9311 2.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2146 3.2629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6409 2.0232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6403 1.1982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9697 0.7151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2241 -0.0697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0491 -0.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3045 0.7141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7423 -0.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9209 -0.6463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4357 -1.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7706 -2.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5955 -2.1521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0771 -1.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9277 1.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6420 0.7918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3568 1.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3528 2.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6380 2.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0652 2.4509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 7 1 0
3 4 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
8 10 2 0
20 21 1 0
2 3 1 0
21 22 2 0
22 17 1 0
14 17 1 0
2 11 1 0
9 23 2 0
5 6 2 0
23 24 1 0
11 12 1 0
24 25 2 0
12 13 2 0
25 26 1 0
6 1 1 0
26 27 2 0
27 9 1 0
1 2 2 0
26 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.43Molecular Weight (Monoisotopic): 369.1590AlogP: 4.78#Rotatable Bonds: 5Polar Surface Area: 82.70Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.14CX Basic pKa: 7.53CX LogP: 4.40CX LogD: 4.05Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.47Np Likeness Score: -1.67
References 1. Mahboobi S, Sellmer A, Eswayah A, Elz S, Uecker A, Böhmer FD.. (2008) Inhibition of PDGFR tyrosine kinase activity by a series of novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides: a SAR study on the bioisosterism of pyrimidine and imidazole., 43 (7): [PMID:17983688 ] [10.1016/j.ejmech.2007.09.021 ]